Greatest International ANtiinfective Trial (GIANT) with moxifloxacin in the treatment of acute exacerbation of  chronic bronchitis: subanalysis of Chinese data of a global, multicenter, noninterventional study
Yulin Feng1, Faguang Jin2, Shuang Mu3, Hong Shen4, Xiaohong Yang5, Yuling Wang6, Zhenshan Wang7, Yingjun Kong8, Zuke Xiao9, Qiming Feng101Respiratory Department, West China Hospital, Sichuan University, China; 2Respiratory Department, Tang Du Hospital, China; 3Respiratory Department, Peking Universi...
Main Authors: | Yulin Feng, Faguang Jin, Shuang Mu, et al |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-03-01
|
Series: | Clinical Epidemiology |
Online Access: | http://www.dovepress.com/greatest-international-antiinfective-trial-giant-with-moxifloxacin-in--a4062 |
Similar Items
-
Efficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis: a prospective, multicenter, observational study (AVANTI)
by: Chuchalin Alexander, et al.
Published: (2013-01-01) -
Intravenous moxifloxacin in routine hospital treatment of respiratory tract infections in China: results of a multicenter, noninterventional study
by: Chen R, et al.
Published: (2011-04-01) -
Characterisation of exacerbations of chronic bronchitis and COPD in Europe: the GIANT study
by: Marc Miravitlles, et al.
Published: (2009-12-01) -
Prulifloxacin Effectiveness in Moderate-to-Severe Acute Exacerbations of Chronic Bronchitis: Α Noninterventional, Multicentre, Prospective Study in Real-Life Clinical Practice—The “AIOLOS” Study
by: Konstantinos Gourgoulianis, et al.
Published: (2021-01-01) -
Prodrugs of Antiinfective Agents: A Review
by: Mona Piplani, et al.
Published: (2016-02-01)